# Oral Probiotic Supplementation in Pregnancy to Reduce Group B Streptococcus Colonization

> **NCT03407157** · PHASE3 · UNKNOWN · sponsor: **University of British Columbia** · enrollment: 168 (actual)

## Conditions studied

- Group B Streptococcus Carrier in Childbirth

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic supplementation
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03407157
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-16
- **Primary completion:** 2023-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 168 (ACTUAL)
- **Last updated:** 2023-09-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03407157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03407157, "Oral Probiotic Supplementation in Pregnancy to Reduce Group B Streptococcus Colonization". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03407157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*